111 related articles for article (PubMed ID: 18677381)
1. [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas].
Chi YK; Shen Q; Wang JC; Zheng XZ; Hou L; Zhang B
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):363-8. PubMed ID: 18677381
[TBL] [Abstract][Full Text] [Related]
2. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
[TBL] [Abstract][Full Text] [Related]
3. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
4. Gastrokine 1 induces senescence and apoptosis through regulating telomere length in gastric cancer.
Yoon JH; Seo HS; Choi WS; Kim O; Nam SW; Lee JY; Park WS
Oncotarget; 2014 Nov; 5(22):11695-708. PubMed ID: 25344918
[TBL] [Abstract][Full Text] [Related]
5. In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression.
Miracco C; De Santi MM; Luzi P; Lalinga AV; Laurini L; De Nisi MC; Angeloni G; Brogi M; Cardone C; Carducci A; Arcuri F; Tosi P; Rubino G; Pirtoli L
Int J Oncol; 2003 Dec; 23(6):1529-35. PubMed ID: 14612923
[TBL] [Abstract][Full Text] [Related]
6. Telomere-associated factor expression in replicative senescence of human embryonic lung fibroblasts.
Du H; Yang L; Xu XY; Hai L; Han YQ; Shi YX
Genet Mol Res; 2015 Aug; 14(3):9269-76. PubMed ID: 26345860
[TBL] [Abstract][Full Text] [Related]
7. Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.
Kato M; Nakayama M; Agata M; Yoshida K
Tumour Biol; 2013 Apr; 34(2):723-33. PubMed ID: 23247865
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
[TBL] [Abstract][Full Text] [Related]
9. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
Gao J; Zhang J; Long Y; Lu X
Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
[TBL] [Abstract][Full Text] [Related]
10. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
[TBL] [Abstract][Full Text] [Related]
11. POT1 as a terminal transducer of TRF1 telomere length control.
Loayza D; De Lange T
Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
[TBL] [Abstract][Full Text] [Related]
12. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
13. Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.
Lee JE; Oh BK; Choi J; Park YN
Int J Cancer; 2008 Jul; 123(2):264-272. PubMed ID: 18449889
[TBL] [Abstract][Full Text] [Related]
14. [Alterations of MDM2 and p53 genes in bone tumors].
Zhou X; Gao L; Zhe X
Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):270-2. PubMed ID: 10374333
[TBL] [Abstract][Full Text] [Related]
15. TRF1 as a major contributor for telomeres' shortening in the context of obesity.
Grun LK; Teixeira NDR; Mengden LV; de Bastiani MA; Parisi MM; Bortolin R; Lavandoski P; Pierdoná V; Alves LB; Moreira JCF; Mottin CC; Jones MH; Klamt F; Padoin AV; Guma FCR; Barbé-Tuana FM
Free Radic Biol Med; 2018 Dec; 129():286-295. PubMed ID: 30268887
[TBL] [Abstract][Full Text] [Related]
16. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells.
Ning X; Yang S; Wang R; Zhang R; Guo L; Tie J; Cheng Y; Wang G; Wan S; Fang D
Eur J Cancer Prev; 2010 Sep; 19(5):345-51. PubMed ID: 20517159
[TBL] [Abstract][Full Text] [Related]
17. Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.
Poonepalli A; Banerjee B; Ramnarayanan K; Palanisamy N; Putti TC; Hande MP
Genes Chromosomes Cancer; 2008 Dec; 47(12):1098-109. PubMed ID: 18720522
[TBL] [Abstract][Full Text] [Related]
18. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
[TBL] [Abstract][Full Text] [Related]
19. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.
Scheel C; Schaefer KL; Jauch A; Keller M; Wai D; Brinkschmidt C; van Valen F; Boecker W; Dockhorn-Dworniczak B; Poremba C
Oncogene; 2001 Jun; 20(29):3835-44. PubMed ID: 11439347
[TBL] [Abstract][Full Text] [Related]
20. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
